|
Categories
Pharmaceutical Company
Pharmaceutical Sales
Pharmaceutical
Distributor
Pharmaceutical
Preparation
Pharmaceutical
Jobs
Pharmaceutical
Industry
Pharmaceutical
Drug
Pharmaceutical
Sales Jobs
Pharmaceutical
Product
Pharmaceutical
News
Pharmaceutical
Research
Pharmaceutical
Manufacturer
Pharmaceutical Sales
Rep
Pharmaceutical
Sales Resume
Pharmaceutical
Online
Pharmaceutical
Marketing
Pharmaceutical
Dictionary
Pharmaceutical
Recruiter
Pharmaceutical
Supply
Pharmaceutical
Technology
Pharmaceutical
Advertising
Pharmaceutical
Schools
Companies
Pfizer Pharmaceutical
Wyeth Pharmaceutical
Watson Pharmaceutical
Merck Pharmaceutical
Roche Pharmaceutical
King Pharmaceutical
Teva Pharmaceutical
Aventis
Pharmaceutical
Novartis
Pharmaceutical
Forest
Pharmaceutical
Tap
Pharmaceutical
Shire
Pharmaceutical
Mayne
Pharmaceutical
Millennium
Pharmaceutical
Lilly
Pharmaceutical
Mylan
Pharmaceutical
Kos
Pharmaceutical
Takeda
Pharmaceutical
Endo
Pharmaceutical
Janssen
Pharmaceutical
Barr
Pharmaceutical
Abbott
Pharmaceutical
Reliant
Pharmaceutical
Solvay
Pharmaceutical
Amylin
Pharmaceutical
Vertex
Pharmaceutical
Osi
Pharmaceutical
Bayer
Pharmaceutical
Voyager
Pharmaceutical
Mcneil
Pharmaceutical
Boehringer
Ingelheim
Astra
Zeneca Pharmaceutical
Glaxosmithkline
Pharmaceutical
Novo Nordisk
Pharmaceutical
3m
Pharmaceutical
Eli
Lilly Pharmaceutical
Elan Pharmaceutical
Ivax
Pharmaceutical
Search engines:
Google
Lycos
AltaVista
Yahoo
Mirago
Ask
Teoma
Excite |
|
|
|
Home /
AstraZeneca
AstraZeneca Pharmaceutical
 About AstraZeneca
pharmaceutical
Astra Zeneca discover new medicines that
are designed to improve the health and quality of life of patients around the
world - medicines which are innovative, effective and which offer added
benefits such as reduced side effects or better ways of taking the treatment.
Astra Zeneca also focus on getting the best from every medicine we make by
exploring all the ways it can be used or improved.
At AstraZeneca,
innovation is about more than just research. Astra Zeneca aim to stimulate
continued creativity throughout their organisation by maintaining a culture in
which their people feel valued, energised and rewarded for their ideas and
contribution to Astra Zeneca's success - ideas which can make a difference in
all aspects of our business. Astra Zeneca support and encourage their people in
discovering their own potential, through excellent learning and development
opportunities that are available to them throughout their careers.
With
a global business comes a global responsibility for consistently high standards
of behaviour worldwide. AstraZeneca aim to effectively manage that
responsibility and help to find new ways of bringing benefit to society to
ensure that AstraZeneca continues to be welcomed as a valued member of the
global community.
AstraZeneca was formed on 6 April 1999 through the
merger of Astra AB of Sweden and Zeneca Group PLC of the UK – two
companies with similar science-based cultures and a shared vision of the
pharmaceutical industry.
There's a great deal to explore at AstraZeneca.
Astra Zeneca have research and manufacturing sites in more than 25 countries,
sales in over 100 and an annual turnover in excess of $21 billion. Astra Zeneca
have a 64,000 strong team works across international and technical boundaries
to create innovative treatments for some of the most significant and serious
medical conditions.
In recent years, Astra Zeneca has had breakthroughs
in all their key therapy areas including high-potential therapies for cancer,
gastrointestinal disease, asthma, hypertension, high cholesterol, migraine and
schizophrenia. Each of these new drugs was not only a remarkable scientific,
commercial and professional achievement it was also an event that profoundly
impacted on patient's quality of life.
The future looks set to be just
as exciting. Every year Astra Zeneca spend $3.8 billion on researching new
medicines, a level of investment that has given them one of the strongest
product pipelines in the pharmaceutical industry. As new technology
revolutionises the drug discovery, development and delivery process, the next
few years will see a new era of growth, change and opportunity right across the
Astra Zeneca business.
Latest AstraZeneca pharmaceutical news
Infinity, AZ halt prostate cancer trial. MedImmune’s Mott heads for the exit. Elan wins $55M judgment in patent scrap. DPP-4 inhibitors get spotlight at ADA meeting. SPOTLIGHT: Fortune snubs Big Pharma in employers list. MedImmune to hire 800 in pipeline push. ALSO NOTED: BioSeek to collaborate with Merck KGaA; BioAlliance acquires drug rights; and much more.... Biotech M&A has yet to reach its peak. Sepracor inks $47M IP licensing deal with Arrow. Biopharma execs sign on to tout UK's R&D work. AstraZeneca and Bristol-Myers Squibb Submit New Drug Application in the United States and Marketing Authorisation Application in Europe for ONGLYZA™ (Saxagliptin) for the Treatment of Type 2 Diabetes. Summary Judgment Granted for SEROQUEL Patent Litigation in the US. AstraZeneca Announces Senior Management Changes at Biologics Business Unit, MedImmune. AstraZeneca and Columbia University Medical Center Sign Strategic Research Collaboration to Develop Novel Therapeutics for Diabetes and Obesity. AstraZeneca Submits Seroquel XR™ in Europe for the Treatment of Major Depressive Disorder. AstraZeneca Submits an sNDA for SYMBICORT® for the Treatment of Asthma in Children as Young as Age Six. FDA Approves AstraZeneca’s Seroquel for Maintenance Treatment in Bipolar Disorder. AstraZeneca Submits sNDA for Seroquel XR™ for the Treatment of Generalised Anxiety Disorder – a First for the Atypical Antipsychotic Class of Medicines. EPO Announces Symbicort® European COPD Use Patent Decision. AstraZeneca Files Marketing Application in Europe for EGFR Inhibitor Gefitinib (IRESSA™) in Locally Advanced Pre-Treated Non-Small Cell Lung Cancer. read more
AstraZeneca further information:
www.astrazeneca.co.uk /
www.astrazeneca.com/ /
AstraZeneca news
Page last updated:
09/06/08 |
|
|
|
|
